Case presentation A 3295-gram infant girl was born by elective cesarean section at 37 weeks gestation to a gravida 2, para 1 mother because of a partially cystic mass detected at the base of the coccyx sonographically. The infant had Apgar scores of 9 at both 1 and 5 min. She was in no respiratory distress. Her weight was 75th percentile, and her head circumference (35.5 cm) was 90th percentile, consistent with good intrauterine growth. Platelets were normal, at 214 000/cu-mm. Initial radiographs of the chest and abdomen demonstrated normal heart size and moderate-sized caudal midline mass without calcification ( Figure 1 ). An abdominopelvic magnetic resonance imaging (MRI) scan of the infant was performed (Figure 2 ). This demonstrated a partially solid, partially cystic sacrococcygeal teratoma (SCT), without hypervascularity. The tumor was predominantly external with a small presacral component. Initial alpha-fetoprotein (AFP) level was 49 912 ng ml À1 (normal less than 8). The human chorionic gonadotropin level was 10.3 IU l
À1
(normal less than 5). The patient remained in stable condition and on the seventh postnatal day she was taken to the operating room, where the mass and coccyx were resected.
Denouement and discussion
Histological examination of the resected tumor and coccyx demonstrated malignant teratoma with extensive endodermal sinus tumor and tumor at the resected margins.
SCT is the most common neoplasm found in newborns, occurring with a striking female predominance of 4 to 6:1 (ref. 1). The tumor arises from embryonic blastema present in the human tail bud, which normally regresses by 32 to 35 days of gestation. 2 Sacrococcygeal teratomas have been shown to be an interesting source of human stem cells. 2 To guarantee resection of this embryonic blastema, thus reducing the risk of recurrence, coccygectomy is performed at the time of tumor resection. There is a 37% rate of recurrence of sacrococcygeal teratomas if concomitant coccygectomy is not performed. 3 Sacrococcygeal teratomas are classified according to the Altman classification of the American Academy of Pediatrics, Surgical Section. By this system, the tumor in this patient corresponds to a type 2 lesion. Type 1 is entirely external to the pelvis, type 2 has an external component as well as a small presacral component, type 3 has an external component but a large internal component extending into the abdomen and type 4 is entirely pelvic without an external mass. 1 The majority of patients have type 1 or 2 SCTFapproximately 36% of cases are type 1, 27% type 2, 18% type 3 and 18% type 4 (ref. 6) .
It is also important to identify the giant or rapidly growing, hypervascular sacrococcygeal teratoma. These hypervascular Figure 1 Plain radiograph of the chest and abdomen shows a large pelvic soft tissue mass, consistent with sacrococcygeal teratoma (SCT).
lesions are associated with a very high fetal mortality and a high risk of exsanguinations at the time of surgical resection unless the tumor is devascularized by ligation of the sacral artery. 4 The hypervascular lesions often lead to congestive heart failure from high output shunting and coagulopathy from intratumoral bleeding and consumption of clotting factors. Cross-sectional imaging has an important role in the evaluation of SCT, particularly of the rapidly growing hypervascular SCT. Both sonography and MRI can provide assessment of the vascularity, size and Altman grade of the tumor. Magnetic resonance angiography can be used to demonstrate the course and size of the median sacral artery, which is the usual source of blood supply to SCT. The high-contrast resolution of MRI and its ability to identify tumor margins and vessels makes it preferable to computed tomography for assessing the tumor extent.
The mortality in giant hypervascular SCT is particularly high in the presence of placentomegaly and hydrops. If the affected fetus is a singleton, with normal chromosomes, less than 30 weeks gestation and has high-output congestive heart failure from a type 1 or 2 SCT, then fetal debulking can be successfully performed and can be life saving. 5 However, in patients who do not have rapidly growing, hypervascular SCT, the prognosis depends upon tumor pathology, recurrence and functional impairment post resection. In the neonate without congestive heart failure or coagulopathy, the prognosis is usually good, with 80% of lesions being benign mature teratoma. Yolk sac tumor or endodermal sinus tumor is the most common malignant element in SCT. 3 Malignant tumors are more often found in older patients (beyond 1 years of age), in solid tumors and in intrapelvic tumors. 3 The risk of malignancy is understandably high in type 4 SCT, because these tumors without an external component are characteristically not discovered until after the neonatal period. The risk of malignancy in neonatally diagnosed and excised SCT is very low, approximately 6% (1 of 17 neonatal lesions). Because of early tumor detection, neonates make up only 7% of the patients with malignant SCT. 1, 3 Interestingly, the survival of patients with malignant SCT is very poor with 80% mortality, except in newborns with malignant tumor.
Tumor recurrence is thought to be due to failure to resect completely the tumor and/or coccyx, tumor spillage or failure to pathologically detect malignant elements. 6 The risk of recurrence is approximately 10% for benign, mature SCT. However, some benign SCT cases unfortunately have recurred with malignant elements. The risk of recurrence of benign SCT with immature elements is 33%. The risk of recurrence with malignant elements is 18%. The lower risk of recurrence of malignant teratoma compared with benign, immature teratoma may be due to the use of adjuvant chemotherapy in some cases. The AFP level is an important marker of sacrococcygeal teratoma. 3 After resection of SCT, the AFP level should fall gradually during the months after resection, and attain normal levels by approximately 9 months. 7 Post-surgical problems include fecal soling, constipation, neurogenic bladder and urinary tract infections. The risk depends upon the adequacy of surgical reconstruction of the pelvic floor, buttock and sphincter preservation. Currently, the risk of postoperative functional impairment at major pediatric surgical centers is low, with constipation reported as the most common problem. 8 This patient will be followed up with frequent AFP level measurements and intermittently obtained pelvic MRI. Chemotherapy will be initiated if there is evidence of tumor recurrence based on failure of AFP levels to fall or recurrent mass accumulation. There is a large complex soft tissue mass abutting the coccyx (arrow). The tumor has external and presecral components and contains cystic elements (cystic sacrococcygeal teratoma (SCT)) and solid elements (solid SCT). The cystic part typically can contain serous or sebaceous material, whereas the solid part can contain hair, fat, and/or immature or malignant tissues. The urinary bladder (B) is anterior and superior.
